v3.26.3
XEROX HOLDINGS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF (LOSS) (UNAUDITED) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenues        
Total Revenues $ 1,868 $ 1,961 $ 5,636 $ 4,994
Costs and Expenses        
Research, development and engineering expenses 56 74 187 159
Selling, administrative and general expenses 374 477 1,236 1,223
Goodwill impairment 959 0 959 0
Restructuring and related costs, net 14 59 82 68
Amortization of intangible assets 31 30 91 50
Divestitures 0 0 0 (4)
Non-financing interest expense [1],[2] 93 80 277 168
Other expenses (income), net [1] 24 25 (2) 85
Total Costs and Expenses 2,874 2,261 6,684 5,421
(Loss) before Income Taxes (1,006) (300) (1,048) (427)
Income tax expense 9 460 59 529
Net (Loss) (1,015) (760) (1,107) (956)
Less: Preferred stock dividends, net (4) (4) (11) (11)
Net (Loss) attributable to Common Shareholders $ (1,019) $ (764) $ (1,118) $ (967)
Basic (Loss) per Share (in dollars per share) $ (7.73) $ (6.01) $ (8.57) $ (7.67)
Diluted (Loss) per Share (in dollars per share) $ (7.73) $ (6.01) $ (8.57) $ (7.67)
Sales        
Revenues        
Total Revenues $ 954 $ 993 $ 2,870 $ 2,215
Costs and Expenses        
Cost of goods and services sold 652 788 1,831 1,650
Services, maintenance, rentals and other        
Revenues        
Total Revenues 914 968 2,766 2,779
Costs and Expenses        
Cost of goods and services sold $ 671 $ 728 $ 2,023 $ 2,022
[1] Prior year amounts have been reclassified to conform to the current year's presentation. Refer to Note 1 - Basis of Presentation for additional information
[2] Prior year amounts have been reclassified to conform to the current year's presentation. Refer to Note 1 - Basis of Presentation for additional information.